SCHEMBL4221102

SCHEMBL4221102

CCOC(=O)c1nc(Nc2cccc(CO)c2)nc(Nc2ccccc2OC)c1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 3/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 2/20 0.42
KDM4E B2RXH2 1/20 0.42
RAB9A P51151 1/20 0.42
AURKA O14965 1/20 0.42
NR1I2 O75469 1/20 0.41
AHR P35869 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
SHMT2 P34897 1/20 0.41
MAPT P10636 5/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1749409 0.87 ALDH1A1 (0.41) CDC25BALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL1751684 0.86 GSK3A (0.51) CDC25BALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL4228405 0.82 HSD17B10 (0.45) CDC25BALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL654384 0.79 RAB9A (0.52) SMN1; SMN2NPC1KDM4ERAB9AMAPT
SCHEMBL1749913 0.79 ALDH1A1 (0.44) CDC25BALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL4363788 0.78 KMT2A (0.50) CDC25BALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL1748994 0.78 HSD17B10 (0.48) AURKANR1I2AHRGSK3AGSK3B
SCHEMBL4223368 0.77 GSK3A (0.51) CDC25BALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL1748903 0.77 GSK3A (0.53) ALDH1A1SMN1; SMN2AURKANR1I2AHR
SCHEMBL4230926 0.76 CSNK1D (0.46) CDC25BALDH1A1SMN1; SMN2NPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051494-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed